FR2738916B1 - METHOD FOR EARLY IDENTIFICATION OF AN AUTOIMMUNE DISEASE, USE IN THE FIELD OF DIAGNOSIS AND ASSAY KIT FOR CARRYING OUT THIS METHOD - Google Patents

METHOD FOR EARLY IDENTIFICATION OF AN AUTOIMMUNE DISEASE, USE IN THE FIELD OF DIAGNOSIS AND ASSAY KIT FOR CARRYING OUT THIS METHOD

Info

Publication number
FR2738916B1
FR2738916B1 FR9511029A FR9511029A FR2738916B1 FR 2738916 B1 FR2738916 B1 FR 2738916B1 FR 9511029 A FR9511029 A FR 9511029A FR 9511029 A FR9511029 A FR 9511029A FR 2738916 B1 FR2738916 B1 FR 2738916B1
Authority
FR
France
Prior art keywords
diagnosis
carrying
field
autoimmune disease
assay kit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9511029A
Other languages
French (fr)
Other versions
FR2738916A1 (en
Inventor
Jean Amiral
Anne Marie Vissac
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diagnostica Stago SAS
Original Assignee
Diagnostica Stago SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diagnostica Stago SAS filed Critical Diagnostica Stago SAS
Priority to FR9511029A priority Critical patent/FR2738916B1/en
Priority to PCT/FR1996/001441 priority patent/WO1997011373A1/en
Publication of FR2738916A1 publication Critical patent/FR2738916A1/en
Application granted granted Critical
Publication of FR2738916B1 publication Critical patent/FR2738916B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869—Interleukin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Peptides Or Proteins (AREA)
FR9511029A 1995-09-20 1995-09-20 METHOD FOR EARLY IDENTIFICATION OF AN AUTOIMMUNE DISEASE, USE IN THE FIELD OF DIAGNOSIS AND ASSAY KIT FOR CARRYING OUT THIS METHOD Expired - Fee Related FR2738916B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR9511029A FR2738916B1 (en) 1995-09-20 1995-09-20 METHOD FOR EARLY IDENTIFICATION OF AN AUTOIMMUNE DISEASE, USE IN THE FIELD OF DIAGNOSIS AND ASSAY KIT FOR CARRYING OUT THIS METHOD
PCT/FR1996/001441 WO1997011373A1 (en) 1995-09-20 1996-09-16 Method for the early detection of an autoimmune disease, diagnostic use thereof and assay kit therefor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9511029A FR2738916B1 (en) 1995-09-20 1995-09-20 METHOD FOR EARLY IDENTIFICATION OF AN AUTOIMMUNE DISEASE, USE IN THE FIELD OF DIAGNOSIS AND ASSAY KIT FOR CARRYING OUT THIS METHOD

Publications (2)

Publication Number Publication Date
FR2738916A1 FR2738916A1 (en) 1997-03-21
FR2738916B1 true FR2738916B1 (en) 1997-11-14

Family

ID=9482745

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9511029A Expired - Fee Related FR2738916B1 (en) 1995-09-20 1995-09-20 METHOD FOR EARLY IDENTIFICATION OF AN AUTOIMMUNE DISEASE, USE IN THE FIELD OF DIAGNOSIS AND ASSAY KIT FOR CARRYING OUT THIS METHOD

Country Status (2)

Country Link
FR (1) FR2738916B1 (en)
WO (1) WO1997011373A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK195089A (en) * 1989-04-20 1990-10-21 Morten Bagge Hansen REGULATORY PROTEINS
FR2665769B1 (en) * 1990-08-09 1994-04-29 Serbio DETERMINATION OF THROMBOPENIA ESPECIALLY INDUCED BY HEPARIN BY MEANS OF THE PLATELET FACTOR 4.
EP0651253A1 (en) * 1993-11-02 1995-05-03 Abbott Laboratories Immunoassay for the detection of human autoantibodies

Also Published As

Publication number Publication date
WO1997011373A1 (en) 1997-03-27
FR2738916A1 (en) 1997-03-21

Similar Documents

Publication Publication Date Title
BR9607136A (en) Imaging contrast agents for diagnosis with increased blood retention
FR2608807B1 (en) MULTIPROCESSOR SYSTEM AND LOAD BALANCING METHOD FOR SAID SYSTEM
FR2709559B1 (en) Sonar system for current meter and Loch Doppler.
DE69737870D1 (en) MEDICAMENTS FOR THE DIAGNOSIS OF AUTOIMMUNE DISEASES
DZ3014A1 (en) Medicines for the treatment of hypertension.
EP1408333A3 (en) Diagnosis and treatment of Alzheimer's disease
FR2835255B1 (en) TEST FOR IDENTIFYING BETA-SECRETASE INHIBITORS, METHOD FOR SCREENING THESE INHIBITORS, AND NOVEL BETA-SECRETASE INHIBITORS FOR THEIR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE
IL123834A0 (en) Diagnostic method and kit for determining rh blood group genotype
FR2700615B1 (en) METHOD AND CIRCUIT FOR DETERMINING THE ORIGIN IN THE TIME OF ECHO PULSES.
FR2738916B1 (en) METHOD FOR EARLY IDENTIFICATION OF AN AUTOIMMUNE DISEASE, USE IN THE FIELD OF DIAGNOSIS AND ASSAY KIT FOR CARRYING OUT THIS METHOD
FR2765591B1 (en) METHOD FOR DIAGNOSING ALZHEIMER'S DISEASE
ATE265533T1 (en) MAMMAL CHEMOKINES
OA08313A (en) Apparatus for determining the period of ovulation in women.
FR2795823B1 (en) METHODS AND KITS FOR DIAGNOSING OR MONITORING SYNOVIAL OR OSTEOARTICULAR PATHOLOGY INCLUDING THE USE OF A SPECIFIC MARKER FOR THE DEGRADATION OF SYNOVIAL TISSUE
FR2608767B1 (en) METHOD FOR THE DETECTION AND DETERMINATION OF ANTI- (SPOROZOA OF P. FALCIPARUM) ANTIBODIES IN HUMAN BLOOD AND DIAGNOSTIC KITS FOR CARRYING OUT THIS METHOD
DE60037676D1 (en) METHOD FOR DIAGNOSIS OF RICKETTSIA PULICIS
FR2751637B1 (en) ELECTROCOAGULATION CELL FOR THE TREATMENT OF EFFLUENTS
FR2766927B1 (en) METHODS AND KITS FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE
FI100556B (en) Method for detection of anti-DNA antibodies, diagnostic method, reagent kit and drug for autoimmune diseases
FR2596874B1 (en) ASSEMBLY FOR DETERMINING THE PRESENCE OF OBJECTS, IN PARTICULAR DENTAL TREATMENT INSTRUMENTS, IN HOUSING OR REMOVAL OF SUCH OBJECTS FROM SUCH HOUSING
FR2602851B1 (en) ANTI-RETURN SYSTEM FOR ALL NON-PULSED OR ASPIRATED FLOW PIPES
FR2723590B1 (en) METHOD FOR DETECTION AND IN VITRO DIAGNOSIS KIT OF A PREDISPOSITION FOR MYOCARDIAL INFARCTION
FR2629916B1 (en) SOLID SUPPORT FOR IMMUNOLOGICAL DIAGNOSIS, PROCESS FOR THEIR TREATMENT AND APPLICATION TO IMMUNOLOGICAL DIAGNOSIS
FR2711535B1 (en) External indicator of the pumping stroke in an implanted injection system for drugs.
FR2721405B1 (en) Analysis method for determining the fertilization capacity of a human sperm sample and corresponding kit.

Legal Events

Date Code Title Description
ST Notification of lapse